Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy ...

Learn why even slightly elevated blood sugar levels can put your heart at risk and how simple lifestyle changes can protect your cardiovascular health.

Eli Lilly has seen revenue and earnings soar in recent years.

NEW YORK, NY, UNITED STATES, February 25, 2026 /EINPresswire.com/ -- Peep Nation Health, a leader in natural metabolic ...

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

The American Red Cross urges donors to help the national blood supply recover from a severe blood shortage and empower their health by making an appointment to give blood or platelets in March. As a ...

Ozempic and Wegovy prices will drop by 35% and 50%, respectively, in 2027 as company faces growing competition from cheaper ...

Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.

Obesity, diabetes and high blood pressure are fueling increases in cardiovascular disease, even among much younger women, the American Heart Association said.

Novo Nordisk struck a deal valued at up to $2.1 billion to license drug-delivery technologies from Vivtex to develop next-generation oral medicines for obesity, diabetes and associated diseases.